Osteoporosis Trial, Recruiting NCT06655701 Sponsor: Beylikduzu State Hospital Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT06655701
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who have gone through menopause and have had a bone density scan (DXA) done within the last 6 months.
  • Women whose bone density scan results show either normal bone density (T-scores of -1 or above at the hip and spine) for the control group, or osteoporosis (T-scores of -2.5 or below at the hip and spine) for the osteoporosis group.
  • Women between the ages of 50 and 75 years.

Who may not be able to join:

  • Women who do not wish to take part in the study.
  • Women with a history of neurological diseases, infections, surgeries, or injuries that may have affected bladder control or muscle mass.
  • Women who have been diagnosed with a psychiatric disorder.
  • Women who have problems with memory, thinking, or understanding (cognitive impairments).
  • Women who are taking medications that could affect the study results (confirm with trial site for which medications apply).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (0212) 856 27 40

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beylikduzu State Hospital
Registry
ClinicalTrials.gov
Start date
15 November 2024
Est. completion
15 January 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Presence of Stress Urinary Incontinence:; Incontinence Quality of Life Scale (I-QOL):; Skeletal Muscle Mass:; Handgrip Strength

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov